Please download the dossier by clicking on the dossier button x
×

Chemosensory Receptor Ligand-Based Therapies

  • US 20120177730A1
  • Filed: 01/06/2012
  • Published: 07/12/2012
  • Est. Priority Date: 01/07/2011
  • Status: Abandoned Application
First Claim
Patent Images

1. A pharmaceutical dosage form comprising:

  • (a) a pH 6.5 enterically coated immediate release component comprising metformin hydrochloride and a pharmaceutically acceptable excipient; and

    b) a pH 6.5 enterically coated extended release component comprising metformin hydrochloride and a pharmaceutically acceptable excipient; and

    wherein the combined amount of metformin from both components is less than 400 mg and wherein the metformin has sub-therapeutic plasma AUC and sub-therapeutic plasma Cmax.

View all claims
  • 5 Assignments
Timeline View
Assignment View
    ×
    ×